Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brough

Showing results (841-850 of 871) with videos related to

Pageof 88
Sort By:
Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancerE Harvey-Jones, M Raghunandan, L Robbez-Masson, et al.
Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.
Allergy|June 26, 2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)Milena Sokolowska, Zuzanna M Lukasik, Ioana Agache, et al.
Molecular Cancer Therapeutics|July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor CombinationsAnh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
The Journal of Allergy and Clinical Immunology|December 7, 2021
Food allergy across the globeVanitha Sampath, Elissa M Abrams, Bahman Adlou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Pageof 88

Showing results (841-850 of 871) with videos related to

Sort By:
Pageof 88
Cancer Research|April 17, 2008
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasisSuzanne A Eccles, Andy Massey, Florence I Raynaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancerE Harvey-Jones, M Raghunandan, L Robbez-Masson, et al.
Journal of Medicinal Chemistry|November 21, 2007
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancerPaul A Brough, Wynne Aherne, Xavier Barril, et al.
Allergy|June 26, 2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)Milena Sokolowska, Zuzanna M Lukasik, Ioana Agache, et al.
Molecular Cancer Therapeutics|July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor CombinationsAnh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
The Journal of Allergy and Clinical Immunology|December 7, 2021
Food allergy across the globeVanitha Sampath, Elissa M Abrams, Bahman Adlou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Italian Journal of Dermatology and Venereology|May 10, 2024
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)Giuseppe Argenziano, Francesco Cusano, Monica Corazza, et al.
Pageof 88